Wyo. Code R. 015-0019-1
Effective Date: 11/20/2020 to 09/21/2022
Rule Type: Superceded Rules & Regulations
Reference Number: 015.0019.1.11202020
Section 1. Purpose. The purpose of these rules is to add, delete, and reschedule controlled substances in the Wyoming Controlled Substances Act of 1971. Some changes will be made to similarly control a substance in response to the publication of a final order in the Federal Register designating that substance as a controlled substance under federal law. Other changes will be made at the discretion of the Wyoming Attorney General, in his or her capacity as the Commissioner of Drugs and Substances Control, with the advice of the Advisory Board on Drugs and Substances Control.
Section 2. Authority. The Commissioner of Drugs and Substances Control's rulemaking authority is found at Wyoming Statute § 35-7-1011(a) and (d), which allow the Commissioner to add, delete, and reschedule substances to the control schedules pursuant to the procedures of the Wyoming Administrative Procedure Act.
Section 3. Additional Controlled Substances. The Commissioner of Drugs and Substances Control adds the following substances to Schedule V:
(a) Anti-epileptics:
(i) ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (commonly known as brivaracetam; also referred to as BRV; UCB-34714; Briviact) (including its salts).
(b) Depressants:
(i) Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide], and its salts, isomers, and salts of isomers; and
(ii) Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate]) and its salts; also referred to as 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester.